FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "ArtifactAssessment",
  "id": "179693",
  "meta": {
    "versionId": "13",
    "lastUpdated": "2025-10-21T10:28:59.837Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/certainty-of-evidence",
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-assessment"
    ]
  },
  "language": "en",
  "text": {
    "status": "additional",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-description",
      "valueMarkdown": "This example of a CertaintyOfEvidence Profile shows a recursive pattern of component elements with type/classifier paired values for different aspects of rating the certainty of evidence."
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "179693",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "title": "Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)",
  "citeAs": "Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179693. Revised 2025-10-21. Available at: https://fevir.net/resources/ArtifactAssessment/179693. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179693#json.",
  "artifactReference": {
    "reference": "Evidence/55",
    "type": "Evidence",
    "display": "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"
  },
  "content": [
    {
      "type": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "rating-system",
            "display": "Rating System"
          }
        ]
      },
      "classifier": [
        {
          "coding": [
            {
              "system": "http://hl7.org/fhir/uv/ebm/CodeSystem/evidence-rating-system-classifier-codesystem",
              "code": "GRADE",
              "display": "GRADE"
            }
          ]
        }
      ],
      "freeToShare": true
    },
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/certainty-type",
            "code": "Overall",
            "display": "Overall certainty"
          }
        ]
      },
      "classifier": [
        {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/certainty-rating",
              "code": "low",
              "display": "Low quality"
            }
          ]
        }
      ],
      "freeToShare": true
    }
  ]
}